New COVID vaccine says it's for the ‘senior class' - does it reduce side effects?

The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...
Healio

RSV mRNA vaccine safe, effective for transplant patients

ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...

Moderna Stock Is at a Crossroads. Is the Path Ahead One of Profit or Pain for MRNA?

Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...
Fierce Biotech

ESMO: Moderna's oncology efforts 'make sense' while government skeptical of vaccines

Moderna’s oncology pipeline also includes a Merck-partnered personalized cancer vaccine called intismeran autogene or ...
McKnight's Long-Term Care News

Moderna: Updated COVID-19 vaccine generates strong immune response

The updated formula for Moderna’s COVID-19 vaccine generates a 16-fold increase in antibodies that neutralize the intended SARS-CoV-2 variant target among recipients, according to a press release from ...

Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough in how we treat the disease

"Now we are an oncology company," Moderna CEO Stéphane Bancel told Insider.